Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
Go back to Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients| Edwards Lifesciences (NYSE: EW) | Delayed: 86.61 -0.11 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.72 | 52 Week High | $166.87 | |||
| Open | $86.27 | 52 Week Low | $72.20 | |||
| Day High | $86.92 | P/E | 25.18 | |||
| Day Low | $85.89 | EPS | $3.44 | |||
| Volume | 148,338 | |||||
